HKB's Mouse Cirrhosis Models provide pharmaceutical researchers with robust platforms for investigating progressive hepatic fibrosis leading to cirrhosis. Our validated rodent models utilize chronic CCl4 administration, bile duct ligation, or MCD diet feeding to replicate key features of cirrhosis including extensive fibrosis, nodular regeneration, and hepatocellular dysfunction.